ACRIVON THERAPEUTICS INC (ACRV) Forecast, Price Target & Analyst Ratings

NASDAQ:ACRV • US0048901096

Current stock price

2.09 USD
+0.24 (+12.97%)
At close:
2.0205 USD
-0.07 (-3.33%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACRIVON THERAPEUTICS INC (ACRV).

Forecast Snapshot

Consensus Price Target

Price Target
$12.65
+ 505.17% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 20, 2026
Period
Q1 / 2026
EPS Estimate
-$0.54
Revenue Estimate
282.203K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$12.65
Upside
+ 505.17%
From current price of $2.09 to mean target of $12.65, Based on 15 analyst forecasts
Low
$8.08
Median
$13.26
High
$19.95

Price Target Revisions

1 Month
7.83%
3 Months
7.83%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for ACRV. The average price target is 12.65 USD. This implies a price increase of 505.17% is expected in the next year compared to the current price of 2.09.
The average price target has been revised upward by 7.83% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ACRV Current Analyst RatingACRV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

ACRV Historical Analyst RatingsACRV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
82.67%
ACRV was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACRV.
In the previous month the buy percentage consensus was at a similar level.
ACRV was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-09Piper SandlerMaintains Overweight -> Overweight
2025-11-25HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-14OppenheimerMaintains Outperform -> Outperform
2025-05-16Jones TradingDowngrade Buy -> Hold
2025-05-15OppenheimerMaintains Outperform -> Outperform
2025-03-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-26Citizens Capital MarketsReiterate Market Outperform -> Market Outperform
2025-03-26Cantor FitzgeraldReiterate Overweight -> Overweight
2025-03-26HC Wainwright & Co.Maintains Buy -> Buy
2025-01-31Cantor FitzgeraldInitiate Overweight
2024-11-14BMO CapitalMaintains Outperform -> Outperform
2024-11-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-16Ladenburg ThalmannUpgrade Neutral -> Buy
2024-09-16BMO CapitalReiterate Outperform -> Outperform
2024-09-16JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-09-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-15BMO CapitalReiterate Outperform -> Outperform
2024-05-14HC Wainwright & Co.Maintains Buy -> Buy
2024-04-29Ladenburg ThalmannDowngrade Buy -> Neutral
2024-04-26BMO CapitalMaintains Outperform -> Outperform
2024-04-25JMP SecuritiesMaintains Market Outperform -> Market Outperform
2024-04-25Piper SandlerMaintains Overweight -> Overweight
2024-04-25HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-05Ladenburg ThalmannMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 20, 2026
Period
Q1 / 2026
EPS Estimate
-$0.54
Revenue Estimate
282.203K
Revenue Q2Q
N/A
EPS Q2Q
-5.09%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
16.67%
Revenue (3 Months)
N/A
EPS (1 Month)
-5.27%
EPS (3 Months)
-6.27%

Next Earnings Summary

ACRV is expected to report earnings on 5/20/2026. The consensus EPS estimate for the next earnings is -0.54 USD and the consensus revenue estimate is 282.20K USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ACRV revenue by date.ACRV revenue by date.
N/AN/A
568.17%		N/A
241.87%		N/A
172.89%		N/A
70.71%		N/A
29.70%		N/A
42.82%		N/A
24.03%
EBITDA
YoY % growth
ACRV ebitda by date.ACRV ebitda by date.
-3.16M-16.14M
-410.76%		-32.3M
-100.12%		-66.567M
-106.09%		-88.193M
-32.49%		-82.758M
6.16%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ACRV ebit by date.ACRV ebit by date.
-3.17M-16.18M
-410.41%		-32.66M
-101.85%		-67.103M
-105.46%		-89.199M
-32.93%		-84.114M
5.70%		N/A
-15.03%		N/A
-34.23%		N/A
-10.51%		N/A
23.15%		N/A
59.34%		N/A
219.54%		N/A
140.07%		N/A
40.17%
Operating Margin
ACRV operating margin by date.ACRV operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ACRV eps by date.ACRV eps by date.
N/AN/AN/A-2.73
60.91%		-2.44
10.62%		-2.05
15.98%		N/A
-8.31%		N/A
10.50%		N/A
-11.81%		N/A
24.83%		N/A
59.54%		N/A
149.81%		N/A
421.21%		N/A
59.88%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.54
-5.09%		-0.56
-1.97%		-0.54
-15.33%		-0.57
-9.20%		-0.50
6.74%		-0.52
7.25%		-0.53
2.15%		-0.55
3.90%
Revenue
Q2Q % growth		282.203K394.403K515.1K594.997K
-100.00%
-100.00%
-100.00%
-100.00%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-22.038M
-1.73%		-22.87M
-0.98%		-23.928M
-21.54%		-25.36M
-26.07%		-27.234M
-23.58%		-28.127M
-22.98%		-28.79M
-20.31%		-29.631M
-16.84%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ACRV Yearly Revenue VS EstimatesACRV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
ACRV Yearly EPS VS EstimatesACRV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-2.72%
EPS Next 5 Year
10.81%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
518.24%
Revenue Next 5 Year
305.83%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ACRIVON THERAPEUTICS INC / ACRV Forecast FAQ

What do analysts expect the price target to be for ACRIVON THERAPEUTICS INC (ACRV)?

15 analysts have analysed ACRV and the average price target is 12.65 USD. This implies a price increase of 505.17% is expected in the next year compared to the current price of 2.09.

When does ACRIVON THERAPEUTICS INC (ACRV) report earnings?

ACRIVON THERAPEUTICS INC (ACRV) will report earnings on 2026-05-20.

What are the consensus estimates for ACRV stock next earnings?

The consensus EPS estimate for the next earnings of ACRIVON THERAPEUTICS INC (ACRV) is -0.54 USD and the consensus revenue estimate is 282.20K USD.

Can you provide the analyst count for ACRIVON THERAPEUTICS INC stock?

The number of analysts covering ACRIVON THERAPEUTICS INC (ACRV) is 15.